Condition: Organ Transplantation · Intestine · Sponsor: Universitaire Ziekenhuizen KU Leuven
An immunomodulatory protocol, experimentally-proven to promote T-regulatory dependent graft protective mechanisms was applied in a clinical cohort of 13 intestinal transplant recipients to activate - in a protolerogenic environment - T-regulatory cells. This protocol is the standard of care in the investigators intestinal transplant programme since the first intestinal transplant was performed in october 2000.
This description comes directly from the study's public registry record.
Jacques Pirenne, MD,PhD,MsC · +32 16 34 87 27 · jacques.pirenne@uzleuven.be
Laurens J Ceulemans, MD · +32 16 34 15 45 · laurens.ceulemans@uzleuven.be
Always discuss trial participation with your own doctor first.
| UZ Leuven | Leuven, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02314949